UPDATE: Citi Upgrades Fate Therapeutics (FATE) to Buy
Tweet Send to a Friend
(Updated - November 9, 2021 5:41 AM EST)
Citi analyst Yigal Nochomovitz upgraded Fate Therapeutics (NASDAQ: FATE) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Yigal Nochomovitz upgraded Fate Therapeutics (NASDAQ: FATE) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
